And if the revenues double, triple, quadruple, quintuple, or maybe more? That's why we are here. Many of us feel, with the niche CareClix is etching out, that they stand a chance to eventually have a go at the big boys. That's why the share price is still under a $1. But with that said, many of us feel that is about to change...especially when we see the next 10Q. So that's why we are all discussing what is in front of us and not wasting time looking in the rearview mirror. BTW, did you see the CEO was interviewed on Fox this past week? Lots of free press starting to build. Not many OTC companies get the luxury.